On-treatment platelet reactivity to clopidogrel varies significantly over time after coronary stenting, suggesting that a single time-point assessment may be insufficient.
No takes yet. Share an insight, caveat, or question.
Serial PRI decline after stenting suggests single assessments may miss variability; leaves open whether serial testing refines risk stratification.
Freynhofer et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: